ArticleBMC cancer2026

Hematologic toxicity of immune checkpoint inhibitors: real-world burden and risk profiles from a five-year cohort from the Middle East.

Ali Awada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.